Evidence map›Paper›PMID 34299215›Full record

ArticleInternational journal of molecular sciences2021

Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient.

Luisa Bresadola, David Weber, Christoph Ritzel, Martin Löwer, Valesca Bukur, Özlem Akilli-Öztürk, Julia Becker, Hisham Mehanna, Barbara Schrörs, Fulvia Vascotto and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Luisa BresadolaTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.
David WeberTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.
Christoph RitzelUniversity Medical Center, Johannes Gutenberg University Mainz, Langenbeckstraße 1, 55131 Mainz, Germany.
Martin LöwerTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.
Valesca BukurTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.
Özlem Akilli-ÖztürkTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.
Julia BeckerTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.
Hisham MehannaInstitute of Head and Neck Studies (InHANSE), University of Birmingham, Vincent Drive, Birmingham B15 2TT, UK.ORCID 0000-0002-5544-6224
Barbara SchrörsTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.ORCID 0000-0001-9758-250X
Fulvia VascottoTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.ORCID 0000-0002-9839-3484
Ugur SahinTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.
Anthony KongTRON-Translational Oncology, University Medical Center, Johannes Gutenberg University Mainz, Freiligrathstraße 12, 55131 Mainz, Germany.ORCID 0000-0002-3989-3948
Johannes Gutenberg University Mainz · DEKing's College London · GBUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synchronous primary malignancies occur in a small proportion of head and neck squamous cell carcinoma (HNSCC) patients. Here, we analysed three synchronous primaries and a recurrence from one patient by comparing the genomic and transcriptomic profiles among the tumour samples and determining the recurrence origin. We found remarkable levels of heterogeneity among the primary tumours, and through the patterns of shared mutations, we traced the origin of the recurrence. Interestingly, the patient carried germline variants that might have predisposed him to carcinogenesis, together with a history of alcohol and tobacco consumption. The mutational signature analysis confirmed the impact of alcohol exposure, with Signature 16 present in all tumour samples. Characterisation of immune cell infiltration highlighted an immunosuppressive environment in all samples, which exceeded the potential activity of T cells. Studies such as the one described here have important clinical value and contribute to personalised treatment decisions for patients with synchronous primaries and matched recurrences.

Indexed as

MutationAgedAlcohol DrinkingFatal OutcomeGene Expression ProfilingGenomicsHead and Neck NeoplasmsHumansMaleNeoplasm Recurrence, LocalNeoplasms, Multiple PrimaryNeoplasm StagingSmokersgermline variantsimmune cell infiltrationrecurrent head and neck squamous cell carcinoma (HNSCC)RNA sequencing (RNA-seq)somatic single nucleotide variantssynchronous multiple primary malignancieswhole exome sequencing (WES)

Identifiers

PMID34299215
PMCPMC8305204
OpenAlexW3183049860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.